HME-CONSULT ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  19.0% 16.7% 13.2% 8.8% 7.0%  
Credit score (0-100)  7 9 16 27 35  
Credit rating  B BB BB BB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 -0.0 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  -4.8 -6.0 -8.1 -6.5 -5.3  
EBITDA  -4.8 -6.0 -8.1 -6.5 -5.3  
EBIT  -4.8 -6.0 -8.1 -6.5 -5.3  
Pre-tax profit (PTP)  21.0 -55.0 -51.0 -22.6 -16.3  
Net earnings  21.0 -55.0 -51.0 -22.6 -16.3  
Pre-tax profit without non-rec. items  21.0 -55.0 -51.0 -22.6 -16.3  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  111 56.1 5.1 -17.5 -33.8  
Interest-bearing liabilities  57.2 57.2 57.2 70.5 70.5  
Balance sheet total (assets)  172 117 216 557 1,651  

Net Debt  -115 -59.8 -48.8 33.6 60.8  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -4.8 -6.0 -8.1 -6.5 -5.3  
Gross profit growth  -27.6% -24.5% -35.1% 19.9% 18.1%  
Employees  1 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  172 117 216 557 1,651  
Balance sheet change%  13.9% -32.0% 84.5% 157.8% 196.4%  
Added value  -4.8 -6.0 -8.1 -6.5 -5.3  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -4.0 -5.0 -5.0 -5.0 -5.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% 100.0% 100.0% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  19.5% 19.2% -4.9% -1.6% -0.5%  
ROI %  20.0% 19.7% -9.2% -9.8% -7.4%  
ROE %  20.9% -65.8% -166.9% -8.0% -1.5%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  64.6% 47.9% 2.3% -3.0% -2.0%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  2,380.8% 996.3% 601.5% -517.5% -1,141.8%  
Gearing %  51.5% 102.0% 1,128.8% -403.2% -208.7%  
Net interest  0 0 0 0 0  
Financing costs %  18.4% 144.6% 75.0% 25.2% 15.7%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  2.8 1.9 0.5 0.1 0.0  
Current Ratio  2.8 1.9 0.5 0.1 0.0  
Cash and cash equivalent  172.1 117.0 106.0 36.9 9.8  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -13.9 -21.5 -138.5 -549.6 -1,682.3  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  -5 -6 -8 -7 -5  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  -5 -6 -8 -7 -5  
EBIT / employee  -5 -6 -8 -7 -5  
Net earnings / employee  21 -55 -51 -23 -16